文献速递其他结缔组织病

化学暴露诱导的系统性纤维化疾病:对系统性硬化症病因与发病机制的新见解

Chemical exposure-induced systemic fibrosing disorders: Novel insights into systemic sclerosis etiology and pathogenesis.
PubMed 文献 · Semin Arthritis Rheum · 2020-09-19

综述探讨了毒油综合征(TOS)、嗜酸性粒细胞增多-肌痛综合征(EMS)和肾源性系统性纤维化(NSF)三种化学暴露诱导的系统性纤维化疾病。这些疾病与系统性硬化症(SSc)共享血管病变、慢性炎症细胞浸润及皮肤和内脏纤维化等关键特征。作者提出SSc可能由毒性或生物制剂经内皮细胞内化后,在遗传易感个体中诱导分子改变而致病。

要点

  • TOS、EMS和NSF与SSc共享血管病变、炎症浸润和纤维化三大特征。
  • 化学诱导的系统性纤维化疾病可为SSc病因和发病机制提供线索。
  • SSc可能由毒性或生物制剂经内皮细胞内化后在遗传易感个体中诱发。

核心结论

  • TOS、EMS和NSF与SSc共享血管病变、慢性炎症细胞浸润及皮肤和内脏纤维化等关键特征。
  • 对化学诱导的系统性纤维化疾病机制的研究可为阐明SSc病因和发病机制提供线索。
  • SSc可能由毒性或生物制剂经内皮细胞内化后在遗传易感个体中诱导分子改变而致病。

研究设计与样本

  • 综述文章,聚焦TOS、EMS和NSF三次化学诱导的系统性纤维化疾病暴发。

主要发现

  • TOS、EMS和NSF虽各具独特特征,但均与SSc共享血管病变、慢性炎症细胞浸润及皮肤和内脏纤维化。
  • 化学诱导的系统性纤维化疾病可呈时间局限的暴发流行。

临床怎么用

  • 认识化学暴露诱导的系统性纤维化疾病与SSc的重叠特征,有助于提示SSc的病因学线索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Numerous drugs and chemical substances are capable of inducing exaggerated tissue fibrotic responses. The vast majority of these agents cause localized fibrotic tissue reactions or fibrosis confined to specific organs. Although much less frequent, chemically-induced systemic fibrotic disorders have been described, sometimes occurring as temporally confined outbreaks. These include the Toxic Oil Syndrome (TOS), the Eosinophilia-Myalgia Syndrome (EMS), and Nephrogenic Systemic Fibrosis (NSF). Although each of these disorders displays some unique characteristics, they all share crucial features with Systemic Sclerosis (SSc), the prototypic idiopathic systemic fibrotic disease, including vasculopathy, chronic inflammatory cell infiltration of affected tissues, and cutaneous and visceral tissue fibrosis. The study of the mechanisms and molecular alterations involved in the development of the chemically-induced systemic fibrotic disorders has provided valuable clues that may allow elucidation of SSc etiology and pathogenesis. Here, we review relevant aspects of the TOS, EMS, and NSF epidemic outbreaks of chemically-induced systemic fibrosing disorders that provide strong support to the hypothesis that SSc is caused by a toxic or biological agent that following its internalization by endothelial cells induces in genetically predisposed individuals a series of molecular alterations that result in the development of SSc clinical and pathological alterations.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Piera-Velazquez S, Wermuth PJ, Gomez-Reino JJ, et al. Chemical exposure-induced systemic fibrosing disorders: Novel insights into systemic sclerosis etiology and pathogenesis. Semin Arthritis Rheum. 2020. PMID: 33059296. doi:10.1016/j.semarthrit.2020.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。